H1N1 Influenza (Swine Flu) Clinical Presentation
- Author: Michael Stuart Bronze, MD; Chief Editor: Russell W Steele, MD more...
Manifestations of H1N1 influenza (swine flu) are similar to those of seasonal influenza. Patients present with symptoms of acute respiratory illness, including at least 2 of the following:
Chills and fatigue
Diarrhea and vomiting (possible)
Persons with these symptoms should call their health care provider promptly. If an antiviral agent is warranted, it should ideally be initiated with 48 hours from the onset of symptoms (see Medication). The duration of illness is typically 4-6 days. The infectious period for a confirmed case is defined as 1 day prior to the onset of symptoms to 7 days after onset.
In children, signs of severe disease include apnea, tachypnea, dyspnea, cyanosis, dehydration, altered mental status, and extreme irritability.
In children hospitalized for influenza, neurologic complications are common and sometimes life-threatening. In an effort to assess the extent and range of such complications in this population, Australian investigators in 6 tertiary pediatric referral centers carried out active hospital-based surveillance of 506 children younger than 15 years who had laboratory-confirmed pandemic influenza A (H1N1) 2009 infection (pH1N1'09). Of the 506, 49 (9.7%) had neurologic complications.
Further study findings were as follows:
Patients with neurologic complications tended to be slightly older than those without (median age, 4.8 years versus 3.7 years)
Of patients with neurologic complications, 55.1% had preexisting medical conditions and 42.8% had preexisting neurologic conditions
On presentation, only 36.7% had cough, fever, and coryza or runny nose; 38.7% had only 1 respiratory symptom or none at all
Neurologic complications, in descending order of frequency, included seizure (7.5%), encephalitis or encephalopathy (1.4%), confusion or disorientation (1.0%), loss of consciousness (1.0%), and paralysis or Guillain-Barré syndrome (0.4%)
Intensive care unit (ICU) admission was required in 30.6% of the patients, mechanical ventilation in 24.5%
Mean hospital stay was 6.5 days, mean ICU stay 4.4 days
Two (4.1%) of the 49 patients died
Specific treatment for influenza-related neurologic complications is generally unavailable. Consequently, early diagnosis of influenza, appropriate use of antiviral therapy, and universal influenza vaccination in children are vital. Influenza should be considered as a diagnosis in children with neurologic symptoms, even when few or even no respiratory symptoms are noted.
CDC. Interim Guidance for Clinicians on the Prevention and Treatment of Swine-Origin Influenza Virus Infection in Young Children. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/swineflu/childrentreatment.htm. Accessed: April 30, 2009.
CDC. Interim Guidance on Specimen Collection and Processing for Patients with Suspected Swine Influenza A (H1N1) Virus Infection. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/swineflu/specimencollection.htm. Accessed: April 28, 2009.
Taubenberger JK, Morens DM. 1918 Influenza: the mother of all pandemics. Emerg Infect Dis. 2006 Jan. 12(1):15-22. [Medline].
Bresee J. CDC Podcasts: Swine Flu. Centers for Disease Control and Prevention. Available at http://www2c.cdc.gov/podcasts/player.asp?f=11226. Accessed: April 28, 2009.
Roan S. Swine flu 'debacle' of 1976 is recalled. LA Times. April 27, 2009. Available at http://articles.latimes.com/2009/apr/27/science/sci-swine-history27.
CDC. Swine Flu - Vaccine Safety and Emergency Preparedness. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/vaccinesafety/emergency/swineflu.htm. Accessed: April 29, 2009.
Vellozzi C, Burwen DR, Dobardzic A, Ball R, Walton K, Haber P. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring. Vaccine. 2009 Mar 26. 27(15):2114-20. [Medline].
Nachamkin I, Shadomy SV, Moran AP, Cox N, Fitzgerald C, Ung H, et al. Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome. J Infect Dis. 2008 Jul 15. 198(2):226-33. [Medline].
World Health Organization. Influenza-like illness in the United States and Mexico. WHO Epidemic and Pandemic Alert and Response. Available at http://www.who.int/csr/don/2009_04_24/en/index.html. Accessed: April 27, 2009.
WHO. Influenza A (H1N1): Special Insights. World Health Organization. Available at http://www.who.int/en/. Accessed: September 1, 2009.
McNeil DG Jr. U.S. Declares Public Health Emergency Over Swine Flu. New York Times. April 27, 2009. Available at http://www.nytimes.com/2009/04/27/world/27flu.html?th&emc=th.
U.S. Department of Health and Human Services. Determination That a Public Health Emergency Exists. Available at http://www.hhs.gov/secretary/phe_swh1n1.html. Accessed: April 27, 2009.
CDC. Swine Influenza (Flu). Centers for Disease Control and Prevention. Available at http://www.cdc.gov/h1n1flu/. Accessed: September 1, 2009.
Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009 Jun 18. 360(25):2605-15. [Medline].
Centers for Disease Control and Prevention (CDC). Update: novel influenza A (H1N1) virus infections - worldwide, May 6, 2009. MMWR Morb Mortal Wkly Rep. 2009 May 8. 58(17):453-8. [Medline].
CDC. CDC Estimates of 2009 H1N1 Influenza Cases, Hospitalizations and Deaths in the United States, April - October 17, 2009. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/h1n1flu/estimates_2009_h1n1.htm.
Obama Declares Swine Flu A National Emergency. The New York Times. October 24, 2009. Available at http://www.nytimes.com/reuters/2009/10/24/world/international-uk-flu-usa-obama.html.
Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA. 2009 Nov 4. 302(17):1880-7. [Medline].
Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med. 2010 May 6. 362(18):1708-19. [Medline]. [Full Text].
Update: Influenza A (H3N2)v Transmission and Guidelines - Five States, 2011. MMWR Morb Mortal Wkly Rep. 2012 Jan 6. 60:1741-4. [Medline].
Belongia EA, Irving SA, Waring SC, et al. Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections. JAMA. 2010 Sep 8. 304(10):1091-8. [Medline].
Khandaker G, Zurynski Y, Buttery J, Marshall H, Richmond PC, Dale RC, et al. Neurologic complications of influenza A(H1N1)pdm09: Surveillance in 6 pediatric hospitals. Neurology. 2012 Oct 2. 79(14):1474-1481. [Medline].
CDC. Guidance for Clinicians & Public Health Professionals. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/swineflu/guidance/. Accessed: April 27, 2009.
National Center for Biotechnology Information. Influenza Virus Resource. Available at http://www.ncbi.nlm.nih.gov/genomes/FLU/SwineFlu.html. Accessed: May 4, 2009.
NIAID. NIAID and 2009 H1N1 influenza. National Institute of Allergy and Infectious Diseases. Available at http://www.niaid.nih.gov/topics/flu/h1n1/research/Pages/researchProgram.aspx. Accessed: May 4, 2009.
WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses. World Health Organization. Available at http://www.who.int/csr/resources/publications/swineflu/h1n1_use_antivirals_20090820/en/index.html. Accessed: August 20, 2009.
Graitcer SB, Gubareva L, Kamimoto L, et al. Characteristics of Patients with Oseltamivir-Resistant Pandemic (H1N1) 2009, United States. Emerg Infect Dis. 2011 Feb. 17(2):255-257. [Medline].
Hernandez JE, Adiga R, Armstrong R, et al. Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States. Clin Infect Dis. 2011 Mar. 52(6):695-706. [Medline]. [Full Text].
CDC. Interim Guidance on Antiviral Recommendations for Patients with Confirmed or Suspected Swine Influenza A (H1N1) Virus Infection and Close Contacts. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/swineflu/recommendations.htm. Accessed: April 28, 2009.
Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009. MMWR Morb Mortal Wkly Rep. 2009 Sep 11. 58(35):969-72. [Medline].
Lee VJ, Yap J, Cook AR, Chen MI, Tay JK, Tan BH, et al. Oseltamivir ring prophylaxis for containment of 2009 H1N1 influenza outbreaks. N Engl J Med. 2010 Jun 10. 362(23):2166-74. [Medline].
Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) --- United States, April 2009--August 2010. MMWR Morb Mortal Wkly Rep. 2011 Sep 9. 60:1193-6. [Medline]. [Full Text].
CDC. Interim Guidance - Pregnant women and swine influenza: considerations for clinicians. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/swineflu/clinician_pregnant.htm. Accessed: April 29, 2009.
Yin JK, Khandaker G, Rashid H, Heron L, Ridda I, Booy R. Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta-analysis. Influenza Other Respi Viruses. 2011 Mar 21. [Medline].
US Food and Drug Administration. Influenza Virus Vaccine for the 2013-2014 Season. Available at http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Post-MarketActivities/LotReleases/ucm343828.htm. Accessed: March 15, 2013.
Jackson LA, Chen WH, Stapleton JT, Dekker CL, Wald A, Brady RC, et al. Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons. J Infect Dis. 2012 Sep 15. 206(6):811-20. [Medline]. [Full Text].
CDC 2009 H1N1 vaccination campaign planning checklist. August 31, 2009. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/H1N1flu/vaccination/statelocal/planning_checklist.htm. Accessed: September 1, 2009.
CDC. Novel H1N1 vaccination recommendations. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/h1n1flu/vaccination/acip.htm. Accessed: September 1, 2009.
Pasternak B, Svanström H, Mølgaard-Nielsen D, Krause TG, Emborg HD, Melbye M, et al. Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark. BMJ. 2012 May 2. 344:e2794. [Medline]. [Full Text].
CDC. Interim Guidance for Infection Control for Care of Patients with Confirmed or Suspected Swine Influenza A (H1N1) Virus Infection in a Healthcare Setting. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/swineflu/guidelines_infection_control.htm. Accessed: April 29, 2009.
Zhu FC, Wang H, Fang HH, Yang JG, Lin XJ, Liang XF, et al. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med. 2009 Dec 17. 361(25):2414-23. [Medline].
US Food and Drug Administration. Letter from the Commissioner to Nation’s Health Care Professionals on H1N1 Vaccine Safety. Available at http://www.fda.gov/NewsEvents/PublicHealthFocus/ucm197733.htm. Accessed: January 14, 2010.
Jain S, Benoit SR, Skarbinski J, Bramley AM, Finelli L. Influenza-Associated Pneumonia Among Hospitalized Patients With 2009 Pandemic Influenza A (H1N1) Virus--United States, 2009. Clin Infect Dis. 2012 May. 54(9):1221-1229. [Medline].
Myles PR, Semple MG, Lim WS, Openshaw PJ, Gadd EM, Read RC, et al. Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK. Thorax. 2012 Mar 14. [Medline].
Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009 Aug 8. 374(9688):451-8. [Medline].
Siston AM, Rasmussen SA, Honein MA, Fry AM, Seib K, Callaghan WM, et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA. 2010 Apr 21. 303(15):1517-25. [Medline].
Pierce M, Kurinczuk JJ, Spark P, Brocklehurst P, Knight M. Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study. BMJ. 2011 Jun 14. 342:d3214. [Medline].
CDC. Swine Flu: CDC Offers Clinical Guidance, WHO Raises Alert Level Again. Physician First Watch - Journal Watch. Available at http://firstwatch.jwatch.org/cgi/content/full/2009/430/1. Accessed: April 30, 2009.
Kling J. Triple-Dose Flu Remedy Hastens H1N1 Viral Clearance. Medscape [serial online]. Available at http://www.medscape.com/viewarticle/811132. Accessed: September 24, 2013.
Kumar A, ROSII Study Investigators. Viral Clearance with Standard or Triple Dose Oseltamivir Therapy in Critically Ill Patients with Pandemic (H1N1) 2009 Influenza. Abstract V-1470. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Available at http://www.icaaconline.com/php/icaac2013abstracts/data/papers/2013/V/2013_V-1470.htm. Accessed: September 24, 2013.
WHO. Swine Influenza Frequently Asked Questions. World Health Organization. Available at http://www.who.int/csr/swine_flu/swine_flu_faq_26april.pdf. Accessed: April 27, 2009.